1-24 of 25 Books

Neurobiology of DOPA as a neurotransmitter
By Yoshimi Misu
The Clinical Uses of L-Dopa
The Clinical Uses of L-Dopa
By G. Stern
Developments in treatment for Parkinson's disease
Developments in treatment for Parkinson's disease
By George C. Cotzias

The Treatment of Parkinsonism with L-Dopa
By Marks, John

Parkinson's disease
By Mark F. Lew,Cheryl H. Waters
Catechol derivatives in the skin of young mice
Catechol derivatives in the skin of young mice
By Lennart Cegrell
Catecholamine turnover in central nervous system
Catecholamine turnover in central nervous system
By Torgny Persson
Catechol- and indolamines in some endocrine cell systems
Catechol- and indolamines in some endocrine cell systems
By Hans Tjälve

The interactions of cholinergic and anticholinergic drugs with nigro-neostriatal dopaminergic neurons
By Robyn G. Young
Cardiovascular and renal effects of L-Dopa
Cardiovascular and renal effects of L-Dopa
By T. Budya Tjandramaga
Effects of feeding chicks high and low levels of tyrosine and dopa on toxicity and growth performance
Effects of feeding chicks high and low levels of tyrosine and dopa on toxicity and growth performance
By Judith Jourdain-Poitevien
Biosynthetic studies on the chromophore of pseudobactin from Pseudomonas fluorescens B10
Biosynthetic studies on the chromophore of pseudobactin from Pseudomonas fluorescens B10
By Brian Nowak-Thompson

Age-related dopamine-dependent disorders
By International Symposium on Age-Related Monoamine-Dependent Disorders and Their Modulation by Gene and Gender (1993 Tokyo, Japan)
Synthesis of 6-alkyl derivatives of DOPA via the trans isomers of unsaturated azlactones
Synthesis of 6-alkyl derivatives of DOPA via the trans isomers of unsaturated azlactones
By Abraham Pieter Morgenstern
Parlodel® (bromocriptine mesylate) in the early management of Parkinson's disease
Parlodel® (bromocriptine mesylate) in the early management of Parkinson's disease
By Stanley Fahn
Current concepts in the treatment of Parkinsonism
Current concepts in the treatment of Parkinsonism
By
Pathogenic problems of phenolase enzymatic oxidation of catecholamines and dopa in humans
Pathogenic problems of phenolase enzymatic oxidation of catecholamines and dopa in humans
By E. Koch